Effects of Salmeterol on Walking Capacity in Patients With COPD
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
This study was designed to test the following hypothesis:
The acute changes in exercise tolerance during the endurance shuttle walk will be greater
with salmeterol compared to placebo in patients with chronic obstructive pulmonary disease.